Simplifying Global Compliance
EC Panel Recommends Phased Approach to Risk Evaluation of Nanomaterials
Devices & Diagnostics Letter
Manufacturers of medical devices that contain nanomaterials should use a phased approach to evaluate risk in order to avoid unnecessary testing, an expert committee of the European Commission recommends.
To View This Article:
Buy This Article Now
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing